| GTO ID | GTC3222 |
| Trial ID | NCT05605197 |
| Disease | Pancreatic Cancer |
| Therapy | CAR-T cell |
| Treatment | U87 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | U87 CART in Treatment of Advanced Pancreatic Cancer |
| Year | 2022 |
| Country | China |
| Company sponsor | Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd |
| Other ID(s) | U87-3 |
| Cohort 1 | |||||||||||||
|
|||||||||||||